Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

Statistical Megastudy Turns Up Genetic Surprise for Pravastatin Patients 6/16/04

June 16, 2004 12:32 pm | Articles | Comments

By Catherine Shaffer A new pharmacogenetic study of cholesterol-lowering statin drugs could lead to better treatment for millions of patients. A collaboration among Harvard Medical School, Brigham and Women's Hospital, both in Boston, and the defunct Variagenics Inc., formerly of Cambridge, Mass., published in the June 16 issue of the Journal of the American Medical Association (JAMA)

TOPICS:

Telltale Heart: Celera Diagnostics Finds Markers of Myocardial Infarction Risk 6/15/04

June 15, 2004 11:27 am | Articles | Comments

By Don Monroe Celera Diagnostics (CD), Alameda, Calif., disclosed two more genetic markers that it says are associated with heart-attack risk in caucasians. Although the work is still in an early stage, this type of marker "could be useful in identifying people who should be on statins, or other cholesterol-lowering agents, who otherwise might not be candidates," says Thomas White, chief scientific officer at the company.

TOPICS:

Delivery System for RNAi Gene Therapy Opens Door to the Brain 6/14/04

June 14, 2004 12:02 pm | Articles | Comments

By Catherine Shaffer The use of gene therapy in the treatment of brain cancer is hindered by drug delivery problems. Large molecules such as monoclonal antibodies and viral vectors cannot cross the blood-brain barrier. A featured article in the June 1 issue of Clinical Cancer Research now describes the successful delivery of a nonviral RNAi gene therapy to brain tumors in mice, resulting in a significant increase in survival times.

TOPICS:
Advertisement

Novel Protein Kinases May Lead to Drug Targets for Alzheimer’s Disease 6/11/04

June 11, 2004 9:40 am | Articles | Comments

By Mark Terry Researchers with Proteome Sciences Plc., Cobham, UK, recently identified 12 additional phosphorylation sites on the tau protein. Twenty-five phosphorylation sites had previously been identified on tau, which has been implicated in Alzheimer's disease (AD). Neurofibrillary tangles develop from a hyperphosphorylated form of the tau protein, and these are hypothesized to be the cause of neuronal cell death. By using a proprietary mass spectrometry technology, the ProteoShop toolbox, they were able to analyze and identify specific kinases that have the potential to be drug targets for AD. Results of their study were presented May 27 at the American Society for Mass Spectrometry Meeting in Nashville, Tenn.

TOPICS:

Vertex Continues Collaboration to Combat CF 06/10/04

June 10, 2004 12:14 pm | Articles | Comments

By Don Monroe Vertex Pharmaceuticals Inc., Cambridge, Mass., will get roughly $21 million through 2005 to continue its late-stage drug discovery collaboration with Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the company announced on May 24.

TOPICS:

Is There a Genetic Basis for Who Experiences Drug Side Effects? 6/09/04

June 9, 2004 11:38 am | Articles | Comments

By Don Monroe First Genetic Trust Inc. (FGT), Deerfield, Ill., and GlaxoSmithKline, Brentford, UK, will again collaborate on a study of possible genetic markers associated with adverse drug reactions, FGT announced on May 25.

TOPICS:

NIMH Makes Brain Gene Studies Go Head to Head 6/07/04

June 8, 2004 11:45 am | Articles | Comments

By Aaron Sender Researchers at the National Institute of Mental Health's Clinical Brain Disease Branch (NIMH-CBDB) have begun pitting several microarray platforms against each other, trying to find the ones

TOPICS:

Reporter Vectors

June 8, 2004 9:49 am | Articles | Comments

Promega Rapid Response™ Reporter Vectors reduce the risk of secondary effects and allow measurement of smaller and more transient changes in transcription compared to their predecessors.

TOPICS:
Advertisement

Array-Ready Oligo Set For Xenopus Tropicalis Genome

June 8, 2004 9:49 am | Articles | Comments

Array-Ready Oligo Set for the Xenopus tropicalis genome contains 10,898 70-mer probes representing Xenopus transcripts.

TOPICS:

Identify Differentially Expressed Genes

June 8, 2004 9:49 am | Articles | Comments

GeneFishing™ Technology offers a unique approach for identifying only authentic Differentially Expressed Genes (DEGs) in two or more nucleic acid samples. This technology improves specificity of PCR amplification, enabling researchers to find only real PCR products as a result.

TOPICS:

RNA Amplification, Labeling

June 8, 2004 9:49 am | Articles | Comments

The Ovation™ Biotin RNA Amplification and Labeling System is offered for use on Affymetrix GeneChip® arrays. IT is validated for reproducibility, fidelity, and sensitivity with GeneChip arrays, using only 5ng of total RNA.

Isolate Genomic DNA From Tissue

June 8, 2004 9:49 am | Articles | Comments

UltraClean™ Tissue DNA Kit is offered for the isolation of genomic DNA from animal tissues, cultured cells or rodent tails. Samples are homogenized using timesaving, bead beating technology and DNA is recovered using a silica spin column format in just 20 minutes.

Custom Analyte Specific Reagent (ASR) Oligonucleotide Synthesis

June 8, 2004 9:49 am | Articles | Comments

Invitrogen Corporation offers custom oligonucleotides manufactured according to Quality System Regulations set forth by the US Food and Drug Administration (FDA).

TOPICS:

Transfection Of siRNAs By Electroporation

June 8, 2004 9:49 am | Articles | Comments

The BTX Electroporation System, ECM 830 was cited in the Journal of Immunology in the paper RNA

Purify DNA From Gram Positive Bacteria

June 8, 2004 9:49 am | Articles | Comments

MasterPure™ Gram Positive DNA Purification Kit (EPICENTRE) provides all of the reagents needed to purify DNA specifically from gram-positive bacteria. With this kit, complete, enzymatic lysis of the bacteria results in high yields of high molecular weight, PCR-ready DNA.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading